| 논문분류 | 춘계학술대회 초록집 |
|---|---|
| 제목 | Clinical Outcomes of Kidney Transplant Recipients with Positive Luminex and Negative Crossmatch |
| 저자 | Tae Hyun Ban, Eun Jeong Ko, Eun-Jee Oh, Bum Soon Choi, Cheol Whee Park, Yeong Jin Choi, Yong-Soo Kim, Byung Ha Chung, Chul Woo Yang |
| 출판정보 | 2019; 2019(1): |
| 키워드 | Kidney transplantation | donor specific anti-HLA antibod | crossmatch | rejection | graft survival |
| 초록 | Immunoassays such as crossmatch (XM) donor specific anti-HLA antibody (HLA-DSA) are important studies for predicting antibody mediated rejection (AMR) after kidney transplantation (KT). However, clinical outcome of kidney transplant recipients (KTRs) with negative XM (XM (-)) and low HLA-DSA levels is unclear. We investigated the clinical outcome of KTRs with XM (-) and low HLA-DSA levels. We reviewed who underwent transplantation from January 2010 to July 2018 at single center. The low level of HLA-DSA was defined as mean flurescent intensity less than 5000 with the luminex method. Exclusion criteria were patients with deceased donor transplantation, ABO incompatible KT, transplantation with negative HLA-DSA (HLA-DSA(-)) and positive XM (XM(+)), and KT with XM(-) and HLA-DSA mean flurescent intensity more than 5000. Finally, a total of 631 patients were included and divided into three groups as followed: HLA-DSA(-) and XM(-) (the CON group; n=538), low HLA-DSA level and XM(-) (the LoDSA group; n=58), positive HLA-DSA (HLA-DSA(+)) and XM(+) (the PosXM group; n=35). The LoDSA group did not receive desensitization therapy. The development of acute AMR within 6 months, allograft survival and allograft function were compared between the three groups. The LoDSA group had a higher incidence of acute AMR within 6 months than the CON group (14.3% and 1.7%, respectively; p<0.001), but a lower incidence of acute AMR within 6 months than the PosXM group (14.3% and 33.3%, respectively; p<0.05). Overall allograft survival did not differ between the LoDSA and the CON groups (p>0.05), but both groups exhibited a better survival rate than the PosXM group (p<0.001 for both). The renal function of functioning allograft was not different in all groups during follow-up period. KT without desensitization in patients with low HLA-DSA levels and XM (-) has an increased risk for acute AMR in a short-term follow-up after transplantation. |
| 원문(PDF) | PDF 원문보기 |